Cargando…
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study
OBJECTIVES: VSL#3 is a high-potency probiotic mixture that has been used successfully in the treatment of pouchitis. The primary end point of the study was to assess the effects of supplementation with VSL#3 in patients affected by relapsing ulcerative colitis (UC) who are already under treatment wi...
Autores principales: | Tursi, Antonio, Brandimarte, Giovanni, Papa, Alfredo, Giglio, Andrea, Elisei, Walter, Giorgetti, Gian Marco, Forti, Giacomo, Morini, Sergio, Hassan, Cesare, Pistoia, Maria Antonietta, Modeo, Maria Ester, Rodino', Stefano, D'Amico, Teresa, Sebkova, Ladislava, Sacca', Natale, Di Giulio, Emilio, Luzza, Francesco, Imeneo, Maria, Larussa, Tiziana, Di Rosa, Salvatore, Annese, Vito, Danese, Silvio, Gasbarrini, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180711/ https://www.ncbi.nlm.nih.gov/pubmed/20517305 http://dx.doi.org/10.1038/ajg.2010.218 |
Ejemplares similares
-
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis
por: Tursi, Antonio, et al.
Publicado: (2023) -
VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial
por: Rohatgi, Sarika, et al.
Publicado: (2015) -
Real‐world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey
por: Nardone, Olga Maria, et al.
Publicado: (2023) -
Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?
por: D’Amico, Ferdinando, et al.
Publicado: (2023) -
Landscape of new drugs and targets in inflammatory bowel disease
por: Vieujean, Sophie, et al.
Publicado: (2022)